Harrow (HROW) Net Income Growth (5y) (2015 - 2026)
Harrow (HROW) Net Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Harrow | 1.41 Bn | 1.31 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -164.39% |
| Dec 31, 2025 | 55.46% |
| Sep 30, 2025 | -34.75% |
| Jun 30, 2025 | 84.21% |
| Mar 31, 2025 | -6.59% |
| Dec 31, 2024 | 21.12% |
| Sep 30, 2024 | 18.35% |
| Jun 30, 2024 | -21.75% |
| Mar 31, 2024 | -26.17% |
| Dec 31, 2023 | -20.16% |
| Sep 30, 2023 | -11.80% |
| Jun 30, 2023 | -29.75% |
| Mar 31, 2023 | -13.59% |
| Dec 31, 2022 | 18.94% |
| Sep 30, 2022 | -2.58% |
| Jun 30, 2022 | -44.06% |
| Mar 31, 2022 | 13.40% |
| Sep 30, 2021 | 8.50% |
| Jun 30, 2021 | 22.97% |
| Mar 31, 2021 | 15.42% |